SCHEMBL8897017

SCHEMBL8897017

CC(C)C[C@H](O)[C@@H](O)CC(C(N)=O)C(Cc1nccs1)C(N)=O

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
FDPS P14324 1/20 0.41
HSPA5 P11021 1/20 0.37
HSPA2 P54652 1/20 0.37
FFAR2 O15552 1/20 0.36
CYP3A4 P08684 1/20 0.33
ACACB O00763 1/20 0.33
LMNA P02545 1/20 0.33
XBP1 P17861 1/20 0.33
GCK P35557 1/20 0.32
REN P00797 1/20 0.32
ALDH1A1 P00352 1/20 0.31
TSHR P16473 1/20 0.31
SLC6A3 Q01959 1/20 0.31
CYP2C19 P33261 1/20 0.31
ALOX15 P16050 1/20 0.31
ALOX12 P18054 1/20 0.31
MMP9 P14780 1/20 0.31
MMP8 P22894 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4026302 0.75 FDPS (0.51) FDPSHSPA5HSPA2CYP3A4ACACB
SCHEMBL8894520 0.73 GABRA5 (0.42) RENALDH1A1
SCHEMBL15592495 0.71 FDPS (0.50) FDPSHSPA5ACACBLMNAXBP1
SCHEMBL21299172 0.70 FDPS (0.53) FDPSHSPA5CYP3A4ACACBALDH1A1
SCHEMBL6385699 0.70 FDPS (0.53) FDPSHSPA5CYP3A4ACACBALDH1A1
SCHEMBL24387763 0.70 FDPS (0.45) FDPSHSPA5HSPA2FFAR2CYP3A4
SCHEMBL27120255 0.70 FDPS (0.45) FDPSHSPA5HSPA2FFAR2CYP3A4
SCHEMBL2047231 0.70 FDPS (0.51) FDPSACACBLMNAXBP1ALDH1A1
SCHEMBL2035542 0.69
SCHEMBL104654 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5693619-A ENZYME INHIBITORS; ADMINISTERED TO TREAT CONGESTIVE HEART FAILURE AND HYPERTENSION BOEHRINGER INGELHEIM (CANADA), LTD. (CA) 1997-12-02 US claimed